#SB010 #ResMed #Stock #Analysis #Healthcare #Investment #Insights
Take a deep dive into #ResMed a global leader in medical device development and cloud-based software. Uncover the story behind ResMed’s 35-year rein, its history, operations, financials, and investment potential.
Established in 1989 by Dr. Peter Farrell, ResMed is dual-listed on the NYSE and ASX as $RMD. With a primary focus on the US market, constituting 65% of its sales, it gained significant attention in Australia and was one of the most talked about stocks in 2023. Operating globally, ResMed employs 10,000+ people, showcasing a strong tech presence with 9,700 patents.
Whether you’re a seasoned investor or just dipping your toes, Stock Break is your opportunity to dive into public companies to get a better understanding of their business activity, fundamentals, and potential. Hosted by market analyst Josh Gilbert.
So is ResMed a buy, hold, or sell? Let us know in the comments 💬
#eToro #investmentinsights #stockstobuy #ResMed #healthcare #cloudbasedstocks
Also if there is a stock you would like us to break down let us know in the comments.
Invest in ResMed 👉 https://www.etoro.com/markets/rmd.asx
Follow for more expert insights on eToro social media channels: 👇
YouTube: https://www.youtube.com/@etoro?sub_confirmation=1
eToro’s platform: https://www.etoro.com/
Facebook: https://www.facebook.com/etoro/
Twitter: https://twitter.com/eToro
Instagram: https://www.instagram.com/etoro_offic…
LinkedIn: https://www.linkedin.com/company/etoro/
TikTok: https://www.tiktok.com/@etoro_official
#etoro
eToro’s official YouTube channel, your trusted source for insightful trading tips, market analysis, interviews, and tutorials to help you make the most of our innovative investing platform.
source
